|
Investigational Drug for Severe AD Shows Promise in U
A new drug, memantine, may be the first to slow disease progression in patients with advanced Alzheimer’s disease (AD) and significantly reduce the economic burden of caring for them. |
|
Misperceptions Discourage Elderly Patients From Seeking Help for Memory Problems
Fear, embarrasment and a belief that it is a normal sign of aging are among factors that keep older individuals with diminishing memory from seeking help. |
|
According to a Retrospective Study …Alcohol Block of Trigeminal Nerve Treats Neuralgia
Alcohol blocks of the trigeminal nerve are no longer widely used, but South Korean investigators believe they are still valuable for outpatient management of trigeminal neuralgia, particularly for elderly patients and those unable to undergo more extensive surgery. |
|
Migraine Curve Useful as a Clinical Tool
While remediation of pain is the traditional focal point of migraine management, pain is only one part of the entire migraine symptom spectrum. |
|
Vascular Depression Is Gender-Specific
|
|
DBS Electrical Parameters Confirmed for P
|
|
Botulinum Toxin Reduces Disability, ~Medication Use in Chronic Headache
|
|
Triptan Eases Acute Migraine Symptoms
|
|
Sinus Headaches May Actually Be Migraines
|
|
Depression Common and Treatable ~In Patients With Myocardial Infarction
|
|
New Instrument Predicts Youth Violence
|
| SPECIAL EDUCATION FEATURES |
|
Guide to Psychotropics in the Elderly 2002
Treatment options for a variety of neuropsychiatric conditions in the elderly continue to develop at a rapid pace. Treatment of schizophrenia, psychosis, and behavioral disturbances in dementia has moved from mentality of tranquilization to more specific treatment of target behaviors with a wide variety of medications. The following tables summarize the current state of the art of psychotropic drug treatment of the above-mentioned neuropsychiatric disorders of the elderly. If you are seeking law advice from drug interactions Minneapolis personal injury lawyers have helped many victims. |
|
Multiple Sclerosis: A Guide to Disease-Modifying Therapies
This educational clinical review compares the current disease-modifying therapies for multiple sclerosis. |
|
Managing Schizophrenia: A Comprehensive Primer 2002
Despite substantial research advances during the past 2 decades, schizophrenia remains one of the most challenging illnesses that psychiatric clinicians treat in their everyday practices. The disease affects a myriad of psychologic functions and robs afflicted individuals of many of the most basic things that are taken for granted in day-to-day life. In spite of the introduction of a range of more effective pharmacologic and psychologic/psychosocial treatments than were previously available, patient outcomes frequently fall far below clinicians' goals. |